Beranda › Lupus › Georgia › Atlanta
Uji klinis Lupus di Atlanta, GA
6 studi untuk Lupus mencari peserta di lokasi sekitar Atlanta (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.
Teks studi resmi (Bahasa Inggris)
Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →
A Study of Enpatoran in Participants With Cutaneous Manifestations of Lupus With or Without Systemic Disease
Menerima pesertaFase 3
- Emory University School of Medicine, Atlanta
A Study to Investigate the Safety, Tolerability, and Efficacy of AZD0120 in Adults With Refractory SLE
Menerima pesertaFase 1/2
- Research Site, Atlanta
A Study in Participants With Active Systemic Lupus Erythematosus With Inadequate Response to Glucocorticoids and ≥2 Immunosuppressants
Menerima pesertaStudi observasional
- Local Institution - 0069, Atlanta
RESET-SLE: A Phase 1/2 Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Systemic Lupus Erythematosus
Menerima pesertaFase 1/2
- Emory University, Atlanta
Effects of Stopping Hydroxychloroquine in Elderly Lupus Disease
Menerima pesertaFase 3
- Emory University School of Medicine, Atlanta
Lupus Landmark Study: A Prospective Registry and Biorepository
Menerima pesertaStudi observasional
- Emory University, Atlanta
Uji klinis Lupus di kota lain
- New York City, NY18 studi
- Houston, TX13 studi
- Durham, NC12 studi
- Washington, DC10 studi
- Miami, FL10 studi
- Tampa, FL9 studi
- Philadelphia, PA9 studi
- Clearwater, FL8 studi
- Santa Monica, CA8 studi
- Oklahoma City, OK8 studi
- Boston, MA8 studi
- Los Angeles, CA8 studi
Studi lain di Atlanta
- Kanker (semua jenis)49 studi
- Kanker Paru Non-Sel Kecil47 studi
- Kanker Payudara41 studi
- Mieloma Multipel41 studi
- Kanker Prostat33 studi
- Leukemia Mieloid Akut30 studi
- Kanker Ovarium29 studi
- Kanker Paru29 studi
- Kanker Kolorektal29 studi
- Kanker Metastatik28 studi
- Gagal Jantung25 studi
- Gangguan Depresi Mayor25 studi
Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.